Bristol-Myers Squibb

Lotte Biologics to break ground on 1st local CDMO plant in 2024

South Korea’s Lotte Biologics Co. is set to start building its first local facility for drug manufacturing next year, aiming for 400,000 liter...

Samsung Biologics wins $242 mn order from Bristol Myers Squibb

Samsung Biologics Co., the world’s largest contract drugmaker, said on Monday it has signed an agreement to produce $242 million worth of anti...

Lotte to buy BMS' biologics plant in Syracuse for $160 mn

South Korea's Lotte Group has agreed to buy Bristol Myers Squibb's (BMS) biologics plant in Syracuse in the state of New York for $160 million, the ...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay

Hanwha in talks to buy five-star hotel Paraspara Seoul

Kia's Lego-like PV5 with 16 variants to hit market in July

Stray Kids make K-pop history with landmark stadium show in Germany

S.Korea’s most prominent business leader returns with all charges cleared